Literature DB >> 11309621

Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10.

S H Chiang1, C A Baumann, M Kanzaki, D C Thurmond, R T Watson, C L Neudauer, I G Macara, J E Pessin, A R Saltiel.   

Abstract

The stimulation of glucose uptake by insulin in muscle and adipose tissue requires translocation of the GLUT4 glucose transporter protein from intracellular storage sites to the cell surface. Although the cellular dynamics of GLUT4 vesicle trafficking are well described, the signalling pathways that link the insulin receptor to GLUT4 translocation remain poorly understood. Activation of phosphatidylinositol-3-OH kinase (PI(3)K) is required for this trafficking event, but it is not sufficient to produce GLUT4 translocation. We previously described a pathway involving the insulin-stimulated tyrosine phosphorylation of Cbl, which is recruited to the insulin receptor by the adapter protein CAP. On phosphorylation, Cbl is translocated to lipid rafts. Blocking this step completely inhibits the stimulation of GLUT4 translocation by insulin. Here we show that phosphorylated Cbl recruits the CrkII-C3G complex to lipid rafts, where C3G specifically activates the small GTP-binding protein TC10. This process is independent of PI(3)K, but requires the translocation of Cbl, Crk and C3G to the lipid raft. The activation of TC10 is essential for insulin-stimulated glucose uptake and GLUT4 translocation. The TC10 pathway functions in parallel with PI(3)K to stimulate fully GLUT4 translocation in response to insulin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11309621     DOI: 10.1038/35073608

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  144 in total

1.  Negative regulation of Rap1 activation by the Cbl E3 ubiquitin ligase.

Authors:  Yuan Shao; Chris Elly; Yun-Cai Liu
Journal:  EMBO Rep       Date:  2003-04       Impact factor: 8.807

2.  H-Ras signaling and K-Ras signaling are differentially dependent on endocytosis.

Authors:  Sandrine Roy; Bruce Wyse; John F Hancock
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

3.  Small GTP-binding protein TC10 differentially regulates two distinct populations of filamentous actin in 3T3L1 adipocytes.

Authors:  Makoto Kanzaki; Robert T Watson; June Chunqiu Hou; Mark Stamnes; Alan R Saltiel; Jeffrey E Pessin
Journal:  Mol Biol Cell       Date:  2002-07       Impact factor: 4.138

4.  Cloning and characterization of Cbl-associated protein splicing isoforms.

Authors:  Mei Zhang; Akiko Kimura; Alan R Saltiel
Journal:  Mol Med       Date:  2003 Jan-Feb       Impact factor: 6.354

5.  TCGAP, a multidomain Rho GTPase-activating protein involved in insulin-stimulated glucose transport.

Authors:  Shian-Huey Chiang; Joseph Hwang; Marie Legendre; Mei Zhang; Akiko Kimura; Alan R Saltiel
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

Review 6.  Regulation of endocytic traffic by Rho GTPases.

Authors:  Britta Qualmann; Harry Mellor
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

7.  SKIP negatively regulates insulin-induced GLUT4 translocation and membrane ruffle formation.

Authors:  Takeshi Ijuin; Tadaomi Takenawa
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

Review 8.  Genetics of insulin resistance.

Authors:  Maria M Mercado; John C McLenithan; Kristi D Silver; Alan R Shuldiner
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

9.  Lipid Raft targeting of the TC10 amino terminal domain is responsible for disruption of adipocyte cortical actin.

Authors:  June Chunqiu Hou; Jeffrey E Pessin
Journal:  Mol Biol Cell       Date:  2003-07-25       Impact factor: 4.138

10.  Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival.

Authors:  Jeffrey C Rathmell; Casey J Fox; David R Plas; Peter S Hammerman; Ryan M Cinalli; Craig B Thompson
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.